Article

Effects of diabetic retinopathy on early visual outcomes after cataract surgery

Author(s):

According to an e-poster presented by Jagadesh C. Reddy, MD, and Harini Indusekar, BScOptom, at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting in Washington, D.C., patients who have pre-existing DR are less likely to achieve Snellen 20/40 or better vison after cataract surgery compared with the patients with diabetes but without DR.

Patients with pre-existing diabetic retinopathy (DR) do not achieve visual outcomes following cataract surgery as good as those with diabetes mellitus but without DR, according to data presented by Jagadesh C. Reddy, MD, and Harini Indusekar, BScOptom, from Cataract and Refractive Services, Cornea Institute, LV Prasad Eye Institute, Hyderabad, India.

The data was presented in an e-poster at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting in Washington, D.C.

The investigators reached this conclusion after analyzing the cataract surgery data collected from the electronic records of almost 42,000 patients who underwent surgery from January 2016 to February 2020. They focused on identifying the factors that impacted the visual acuity (VA) outcomes, specifically, VA of 20/40 or lower at 5 weeks after the surgery. Reddy and Indusekar then compared the VA of patients with/without diabetes including the patients with/without DR, they explained.

They found that among the patients with diabetes, DR was present in 20% of the eyes.

When broken down by groups, following cataract surgery, the corrected distance VA of 20/40 or higher was reached in 94%, 95%, and 80%, respectively, in the patients who did not have diabetes, those who had diabetes but no DR, and those who had diabetes and DR. This difference reached significance (p < 0.01), the authors reported.

The multivariate analysis also showed that increasing age ( p < 0.01), presence of DR (p < 0.05), need for another surgery (p < 0.01), and body mass index (p < 0.01) were independent risk factor for poor VA outcomes.

The investigators concluded that patients who have pre-existing DR are less likely to achieve Snellen 20/40 or better vison after cataract surgery compared with the patients with diabetes but without DR. The results showed that the patients with diabetes and no DR had VA outcomes that were comparable to the patients without diabetes.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.